TARA BOLERJACK: Open Payments
NPI 1689281057 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 22 payments from 13 companies in 2025. Trend: 2023 $467 · 2024 $286 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62 |
| PFIZER INC. | 3 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $51 |
| Radius Health, Inc. | 2 | $41 |
| SANOFI PASTEUR INC. | 2 | $38 |
| Novo Nordisk Inc | 2 | $30 |
| ABBVIE INC. | 1 | $30 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Boston Scientific Corporation | 1 | $25 |
| Lilly USA, LLC | 1 | $20 |
Products named: JARDIANCE, PREVNAR 20, GEMTESA, Tymlos, Wegovy, UBRELVY, WATCHMAN Access System, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE.
Industry payments across OK — which companies pay providers there.
